I sat in a room at University of California, Berkeley this weekend where a REAL princess, a Nobel-adjacent scientist, and a former NIA director all agreed on one thing:
We've been studying aging wrong.
The Berkeley Conference on Aging & Longevity (BerkeleyCAL) was two days of frontier science that genuinely shifted how I think about what we're building at #SuccediaVentures.
Let me share the few insights I can't stop thinking about:
1. Aging isn't a disease. It's a misread signal.
Dr. Steven Garan's work on phenomics is reframing aging as a communication breakdown β the body sends signals long before disease shows up, but our tools aren't built to listen.
This hit me hard. My family has been reading those signals for 268 years through Traditional Chinese Medicine. Tongue diagnosis. Pulse patterns. Constitution mapping. What Garan is proving with data, my grandmother knew by touch.
2. Women's aging is finally getting its own conversation.
The menopause panel β led by HRH Princess Dr. Haya Al Saud alongside Dr. Dr. Hanadie Yousef, Dr. Greg Cole, and Dr. Garan β asked a question I've been waiting to hear at a scientific conference:
"Why is female menopause rarely talked about at aging conferences?"
Exactly. Women don't just age differently. They age on a completely different biological timeline. And the research funding hasn't caught up.
3. The translation gap is where the real capital and impact lives.
There's extraordinary science happening. Plasma dilution. Cellular senescence. Age reprogramming. Dr. Michael Conboy, Dr. Michael West, Aubrey de Grey β the research is accelerating faster than ever.
4. The people building the future of longevity are remarkably generous.
What surprised me most wasn't the science. It was the openness. Researchers sharing unpublished findings. Investors asking "how can I help?" instead of "what's your traction?" Founders comparing notes instead of guarding playbooks.
I walked in as a venture builder. I walked out with potential advisors, collaborators, and at least three founders I want to feature on #TheLegacyCode podcast.
π Here's what I'm taking from Berkeley:
The future of longevity isn't just biotech. It's the bridge between what science discovers and how real people β especially women β actually access it.
That bridge is what we're building at Succedia Ventures. One venture at a time. Starting with Solunar Wellness, where 268 years of TCM meets AI personalization.
If you're building in longevity, healthspan, or women's health β or investing in it β I want to hear from you. DM me or comment below.
And if you were at BerkeleyCAL this weekend β what was YOUR biggest takeaway? I want to compare notes. π
#BerkeleyCAL #Longevity #Aging #HealthTech #WomensHealth #VentureBuilder #Geroscience #Healthspan #FounderStory
You made this happen and meaningful Dr. Steven A. Garan,Niki G.,Natalie Coles,Scott Summit,Hevolution Foundation,Michael Conboy,Collin Jarvis,Melissa King,Nuno Martins, PhD